Search Results - "Wierzbicki, P. M."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    The Immunoexpression of YAP1 and LATS1 Proteins in Clear Cell Renal Cell Carcinoma: Impact on Patients’ Survival by Wierzbicki, P. M., Kozielec, Z., Krazinski, B. E., Kiezun, J., Godlewski, J., Kmieć, Zbigniew

    Published in BioMed research international (01-01-2018)
    “…The aim of the study was to determine by immunohistochemistry cellular localization and immunoreactivity levels of YAP1 and LATS1 proteins in paired sections…”
    Get full text
    Journal Article
  2. 2

    Differential antitumor effects of vitamin D analogues on colorectal carcinoma in culture by WIERZBICKA, J.M, BINEK, A, AHRENDS, T, KA, J.D. NOWAC, SZYDŁOWSKA, A, TURCZYK, Ł, WĄSIEWICZ, T, WIERZBICKI, P.M, SĄDEJ, R, TUCKEY, R.C, SLOMINSKI, A.T, CHYBICKI, J, ADRYCH, K, KMIEĆ, Z, ŻMIJEWSKI, M.A

    Published in International journal of oncology (01-09-2015)
    “…Colorectal cancer (CRC) is an emerging global problem with the rapid increase in its incidence being associated with an unhealthy lifestyle. Epidemiological…”
    Get full text
    Journal Article
  3. 3

    TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients by Ślebioda, T. J., Bojarska‐Junak, A., Stanisławowski, M., Cyman, M., Wierzbicki, P. M., Roliński, J., Celiński, K., Kmieć, Z.

    Published in Scandinavian journal of immunology (01-10-2015)
    “…Interaction between TL1A and death receptor 3 (DR3) co‐stimulates T cells, induces production of several pro‐inflammatory cytokines and has been linked to…”
    Get full text
    Journal Article
  4. 4

    Decreased Toll-like receptor-5 (TLR-5) expression in the mucosa of ulcerative colitis patients by Stanislawowski, M, Wierzbicki, P M, Golab, A, Adrych, K, Kartanowicz, D, Wypych, J, Godlewski, J, Smoczynski, M, Kmiec, Z

    “…Although there is a convincing evidence supporting an important role for microorganisms in the pathogenesis of Inflammatory Bowel Disease (IBD) which comprises…”
    Get more information
    Journal Article
  5. 5

    Influence of receptor activator of nuclear factor kappa B ligand, osteoprotegerin and interleukin-33 on bone metabolism in patients with long-standing ulcerative colitis by Stanisławowski, M., Wiśniewski, P., Guzek, M., Wierzbicki, P.M., Adrych, K., Smoczyński, M., Sworczak, K., Celiński, K., Kmieć, Z.

    Published in Journal of Crohn's and colitis (01-08-2014)
    “…Ulcerative colitis (UC) is a chronic disease with periods of remission and recurrences. Dysfunction of the local immune response leads to chronic inflammation…”
    Get full text
    Journal Article
  6. 6
  7. 7

    TL 1A as a Potential Local Inducer of IL 17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients by Ślebioda, T. J., Bojarska‐Junak, A., Stanisławowski, M., Cyman, M., Wierzbicki, P. M., Roliński, J., Celiński, K., Kmieć, Z.

    Published in Scandinavian journal of immunology (01-10-2015)
    “…Abstract Interaction between TL 1A and death receptor 3 ( DR 3) co‐stimulates T cells, induces production of several pro‐inflammatory cytokines and has been…”
    Get full text
    Journal Article
  8. 8

    Fragile histidine triad (FHIT) gene is overexpressed in colorectal cancer by Wierzbicki, P M, Adrych, K, Kartanowicz, D, Dobrowolski, S, Stanislawowski, M, Chybicki, J, Godlewski, J, Korybalski, B, Smoczynski, M, Kmiec, Z

    “…FHIT gene, mapped at FRA3B site, encodes human diadenosine triphosphate hydrolase involved in the regulation of cell cycle and nucleotide metabolism. Decreased…”
    Get more information
    Journal Article